Posterior Reversible Encephalopathy Syndrome Secondary to Management of Dimorphic Anemia by Repeated Blood Transfusions: A Case Report
DOI:
https://doi.org/10.37591/rrjom.v8i2.424Keywords:
Posterior reversible encephalopathy syndrome, Anemia, MRI, blood transfusion.Abstract
Posterior reversible encephalopathy syndrome, popularly known asPRES, is defined as a clinicoradiological syndrome which is characterized by symptoms such as headache, seizures, and altered consciousness and characterized by white matter vasogenic edema affecting the posterior occipital and parietal lobes of the brain .We report a 39-year-old woman who was treated by iron and blood transfusion for dimorphic anemia with a hemoglobin (Hb) level of 2 g/dl. Patient developed three episodes of seizures while the convulsions settled after infusion of phenytoin and midazolam. Her consciousness was immediately improved. There was no history of hypertension, convulsions, cardiovascular, renal or neurological diseases before transfusion. She developed typical manifestations of PRES six days after blood transfusion for severe anemia. Her brain magnetic resonance imaging (MRI) revealed T2and flair hyper intensities seen in the bilateral parietal occipital lobes which shows high Apparent Diffusion Coefficient (ADC) signal and multiple micro bleeds on susceptibility weighted imaging (SWI). The clinical features as well as MRI findings lead to diagnosis of PRES. Patient responded well to anticonvulsants prescribed by the physician and was discharged in a stable condition with no signs and symptoms after treatment.
Keywords: Posterior reversible encephalopathy syndrome, anemia, magnetic resonance imaging (MRI), blood transfusion
Cite this Article
Prathyusha AS, Rekha MM. Posterior Reversible Encephalopathy Syndrome Secondary to Management of Dimorphic Anemia by Repeated Blood Transfusions: A Case Report. Research & Reviews: Journal of Medicine. 2018; 8(2): 6–8p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |